Schrödinger, Inc. (NASDAQ:SDGR) Insider Margaret Dugan Sells 1,531 Shares

Schrödinger, Inc. (NASDAQ:SDGR) insider Margaret Dugan sold 1,531 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total transaction of $27,221.18. Following the transaction, the insider now directly owns 13,469 shares in the company, valued at approximately $239,478.82. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Schrödinger Stock Performance

Shares of Schrödinger stock opened at $17.92 on Thursday. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $38.00. The company has a market capitalization of $1.30 billion, a P/E ratio of -6.69 and a beta of 1.50. The company has a fifty day moving average of $19.36 and a 200 day moving average of $21.39.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings data on Wednesday, July 31st. The company reported ($0.74) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.85) by $0.11. The firm had revenue of $47.33 million for the quarter, compared to analysts’ expectations of $40.19 million. Schrödinger had a negative net margin of 100.42% and a negative return on equity of 38.38%. Analysts forecast that Schrödinger, Inc. will post -2.19 EPS for the current year.

Institutional Trading of Schrödinger

A number of large investors have recently made changes to their positions in SDGR. Nisa Investment Advisors LLC lifted its stake in shares of Schrödinger by 145.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock valued at $27,000 after purchasing an additional 837 shares during the last quarter. GAMMA Investing LLC raised its holdings in Schrödinger by 49.5% during the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock valued at $41,000 after buying an additional 703 shares during the period. nVerses Capital LLC bought a new stake in Schrödinger in the second quarter worth $66,000. PNC Financial Services Group Inc. boosted its stake in Schrödinger by 186.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock worth $76,000 after buying an additional 1,385 shares during the period. Finally, Quest Partners LLC boosted its stake in Schrödinger by 1,005.6% during the second quarter. Quest Partners LLC now owns 4,555 shares of the company’s stock worth $88,000 after buying an additional 4,143 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Leerink Partners assumed coverage on shares of Schrödinger in a report on Tuesday, July 2nd. They set an “outperform” rating and a $29.00 price target for the company. Morgan Stanley lowered their price objective on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 21st. KeyCorp cut their target price on Schrödinger from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. Finally, Leerink Partnrs raised Schrödinger to a “strong-buy” rating in a research report on Tuesday, July 2nd. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $33.44.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.